The EU Commission conditionally clears a merger in the human and animal healthcare sector (Schering-Plough / Organon BioSciences)

"Mergers: Main developments between 1 September and 31 December 2007"* On 11 October the Commission cleared the proposed acquisition of Organon BS of the Netherlands, a subsidiary of Akzo Nobel active worldwide in human and animal health, by the global pharmaceutical company Schering-Plough Corporation of the US, subject to conditions. The Commission found that the proposed transaction as

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

  • J G Associates (Brussels)
  • DG COMP (Brussels)

Quotation

John Gatti, Mary Loughran, The EU Commission conditionally clears a merger in the human and animal healthcare sector (Schering-Plough / Organon BioSciences), 11 October 2007, e-Competitions Bulletin October 2007, Art. N° 37723

Visites 429

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues